Dr. Furhan Yunus
Claim this profileMobile Infirmary Medical Center
Studies Skin Cancer
Studies Cancer
4 reported clinical trials
25 drugs studied
Area of expertise
1Skin Cancer
p16 positive
p16 negative
Stage IV
2Cancer
Stage IV
BRAF positive
Affiliated Hospitals
Clinical Trials Furhan Yunus is currently running
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
Encorafenib/Binimetinib/Nivolumab vs Ipilimumab/Nivolumab
for Melanoma
This phase II trial compares the effect of encorafenib, binimetinib, and nivolumab versus ipilimumab and nivolumab in treating patients with BRAF- V600 mutant melanoma that has spread to the brain (brain metastases). Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Ipilimumab and nivolumab are monoclonal antibodies that may interfere with the ability of tumor cells to grow and spread. This trial aims to find out which approach is more effective in shrinking and controlling brain metastases from melanoma.
Recruiting1 award Phase 223 criteria
More about Furhan Yunus
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Furhan Yunus has experience with
- Cisplatin
- Afatinib
- Binimetinib
- Capivasertib
- Copanlisib
- Dabrafenib
Breakdown of trials Furhan Yunus has run
Skin Cancer
Cancer
Melanoma
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Furhan Yunus specialize in?
Furhan Yunus focuses on Skin Cancer and Cancer. In particular, much of their work with Skin Cancer has involved p16 positive patients, or patients who are p16 negative.
Is Furhan Yunus currently recruiting for clinical trials?
Yes, Furhan Yunus is currently recruiting for 2 clinical trials in Mobile Alabama. If you're interested in participating, you should apply.
Are there any treatments that Furhan Yunus has studied deeply?
Yes, Furhan Yunus has studied treatments such as Cisplatin, Afatinib, Binimetinib.
What is the best way to schedule an appointment with Furhan Yunus?
Apply for one of the trials that Furhan Yunus is conducting.
What is the office address of Furhan Yunus?
The office of Furhan Yunus is located at: Mobile Infirmary Medical Center, Mobile, Alabama 36607 United States. This is the address for their practice at the Mobile Infirmary Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.